Allergic responses to prescription drugs are largely preventable, and incur significant cost to the community both financially and in terms of healthcare outcomes. The capacity to minimise the effects of repeated events rests predominantly with the reliability of allergy documentation in medical records and computerised physician order entry systems (CPoeS) with decision support such as allergy alerts. this paper presents an overview of the nature and extent of adverse drug reactions (aDrs) in australia and other developed countries, a discussion and evaluation of strategies which have been devised to address this issue, and a commentary on the role of coded data in informing this patient safety issue. It is not concerned with pharmacovigilance systems that monitor ADRs on a global scale. There are conflicting reports regarding the efficacy of these strategies. Although in many cases allergy alerts are effective, lack of sensitivity and contextual relevance can often induce doctors to override alerts. Human factors such as user fatigue and inadequate adverse drug event reporting, including aDrs, are commonplace. the quality of and response to allergy documentation can be enhanced by the participation of nurses and pharmacists, particularly in medication reconciliation. The International Classification of Diseases (ICD) coding of drug allergies potentially yields valuable evidence, but the quality of local and national level coded data is hampered by under-documenting and under-coding.
Introduction
Although to a large extent preventable, allergic reactions to drugs are a major cause of iatrogenic injury (Runciman et al. 2003) . Despite advances in health information technology (IT) which should in theory minimise the occurrence of such events (Benkhaial et al. 2009; Runciman et al. 2003; Smith, Dang & Lee 2009) , they result in a significant burden on the community in terms of morbidity, mortality, and cost to the healthcare system. In addition, Hammann et al. (2010) claim that they 'evoke mistrust of pharmacotherapy' (p. 52). Bates and Leape (2000) define an Adverse Drug Event (ADE) as an 'injury resulting from medical intervention related to a drug' (p. 1223) that also encompasses injuries from errors in medication administration.
Adverse Drug Events and Adverse Drug Reactions
1 An Adverse Drug Reaction (ADR) falls under the umbrella of ADE. Bates and Leape posit that the World Health Organization's definition of an ADR (adopted by Australia's Therapeutic Goods Administration) (Australian Nebeker and colleagues (2002) have identified the need to develop a 'taxonomy' of ADEs, observing the need for refinement of the somewhat ambiguous definition of ADEs in order to clarify the literature. For example, it is important to compare the expected adverse effects of a drug with the positive outcomes sought (e.g. hyperkalaemia is an expected side effect of some diuretics).
Government 2010)
2 is restricted, unnecessarily, to incidents that occur when the drug is used appropriately, thereby excluding events caused by preventable errors (Bates & Leape 2000) .
Clinically, ADRs are more specifically differentiated. Type A (intrinsic) reactions extend the 'primary or secondary pharmacologic activity of the drug' (Bates & Leape 2000 : 1223 and tend to be dose-dependent. Type B (idiosyncratic) ADRs are characterised as typically immunological or allergic reactions, generally occurring independently of dose and route of administration (Bates & Leape 2000) . Cresswell and Sheikh (2008) observe that drug allergies are '… characterized by specificity and recurrence on re-exposure' (Cresswell & Sheikh 2008 : 1112 . Importantly, ' ADE' includes Type A ADRs, Type B ADRs 3 , and drug-related events due to medication errors. A 'medication error' can occur in the processes of medication ordering, transcribing, dispensing, or administration, regardless of whether or not the patient sustains associated actual or potential injury (Bates & Leape 2000 : 1224 (AIHW 2009: 97) .
Drug allergies
Drug allergies have varied clinical presentations and can be trivial or life-threatening (Bates & Leape 2000 : 1227 . (Refer to Figure 1 .) It is critical that allergy information be reliable and readily accessible to those who prescribe and administer drugs.
There are four types of hypersensitivity (allergic) reactions: anaphylaxis, for example, constitutes a Type B ADR and is a Type 1 hypersensitivity reaction (Bates & Leape 2000 : 1229 . Whereas iatrogenic injuries can be frequently attributed to ADRs, allergic reactions are generally of the greatest concern because they are potentially severe or fatal (Bates 1999 ); see also (Kuperman et al. 2003) . While allergic reactions to penicillin and its derivatives are relatively well-known in the wider community, other drugs such as sulfa drugs, anticonvulsants, insulin preparations and iodinated X-ray contrast dyes can also cause allergic reactions. For example, an analysis revealed that 19.3% of USA hospital emergency department attendances for ADEs were antibioticassociated: most were attributed to allergic reactions, one-half being due to penicillin and cephalosporin allergies (Shehab et al. 2008) ; (Lutomski et al. 2008; Thong 2010) . Davies et al. (2009) found in the UK that diuretics, opioid analgesics and anticoagulants were most frequently associated with hospital ADRs. (Pourpak, Fazlollahi & Fattahi 2008) from Iran claim that ADRs (allergic and non-allergic reactions) 'complicate 5-15% of therapeutic drug courses'; they write that 'clinical manifestations of allergic reactions range from pruritus and rash to serious reactions such as systemic anaphylaxis and cardiovascular emergencies and they are responsible for 2-3% of hospitalized patients' (p. 24).
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Consequences of Adverse Drug Reactions
The landmark Quality in Australian Health Care Study of in-hospital adverse events (AE) found, in 14,179 records scrutinised, that 15% of patients experiencing general surgery-related AEs, and 41% with internal medicinerelated AEs, suffered permanent disability (Wilson et al. 1995) . A later systematic review by Runciman et al. (2003) of ADEs in Australia showed that 2-4% of hospital admissions were medication-related, and alarmingly, this figure rose to around 30% for patients aged >75 years. They also found that drug administration errors are high and ' [p] revious allergic reactions to drugs may not be recorded more than 75% of the time' (Runciman et al. 2003: 149) . Zhang et al. (2007) carried out a longitudinal study of repeat ADRs (not necessarily allergy-related) in Western Australia (WA) using data from the state's Hospital Morbidity Data System and WA Death Register for the years 1980-2003. They showed that 18.4% of 37,296 people aged ≥60 years who had been admitted with ADR-related illness had repeat ADRs. The incidence of repeat admissions for ADRs in this population increased over the study period.
The occurrence of ADRs is not confined to hospitals. During the period of an Australian study by Miller, Britt and Valenti (2006) , which reviewed 95 million visits to General Practitioners by 17.5 million Australians per annum, 10.4%, or two million of these experienced an ADE, one million of which were classed as 'moderate to severe', and 138,0000 required hospitalisation. Drug allergies accounted for 11% of these ADEs, 23.2% were regarded as being preventable, and 7.6% resulted in hospitalisation.
A comprehensive survey of trends in ADR-related, UK hospital admissions and mortality in 1999-2008, was conducted by Wu et al. (2010) . Their initial analysis of ICD-10 data showed that ADR-related cases comprised 0.9% of admissions, and 'over this period the annual number of ADRs increased by 76.8% (from 42,453 to 75,076), and in-hospital mortality rate increased by 10% (from 4.3% to 4.7%) ' (p.239) . Another analysis of ICD-10 English hospital inpatient data demonstrated that, despite the probable under-reporting of ADRs, they nevertheless represent 0.5% of all hospital admissions and are particularly prevalent in patients aged >60 years (Patel et al. 2007) . A smaller, two-week study in a Scottish acute care hospital found that 2.7% of admissions were attributable to ADRs (Hopf, Watson & Williams 2008) . In common with Patel et al. (2007) and Zhang et al. (2007) , Carrasco-Garrido et al. (2010) also noted that the incidence of ADR-related hospitalisation in Spain is higher in older citizens than in the general population. Their study of the Spanish national surveillance system's ICD-9 External Cause of Injury codes revealed that in 2001-2006, ADRs accounted for 1.69% of hospital admissions, decreasing over the study period. Lapisatepun et al. (2008) reported that 1996 data from the Thai Anaesthesia Incident Monitoring Study Forum revealed that perioperative allergic reactions accounted for 1.6% of anaesthetic adverse events. In France, data collected from 33 hospitals during 1998 showed that 100 (3.19%) admissions were due to ADRs, of whom 78 patients recovered and nine had 'irreversible lesions'; there were no mortalities. Consistent with the afore-mentioned studies, the incidence of ADR-related admission was higher in older patients (Pouyanne et al. 2000) .
The financial burden of ADRs is high. A six-month, prospective study of ADR-related hospital admissions in Merseyside, UK, showed that the financial cost of these admissions (0.15% of which were fatal, and many of which were avoidable) was £466m (Pirmohamed et al. 2004) . Davies et al. (2009) also found in England that ADRs, half of them avoidable, were experienced by one in seven inpatients and increased the average length of stay (ALOS) by 0.25 days per admitted episode.
Notwithstanding the wide variation in figures for ADR-related iatrogenic injury, it is nevertheless clear from the above that this is a serious global problem but one that is, largely, potentially avoidable. The availability and reliability of health information in this area can be compromised by irregularities in data collection and patient-related documentation, while prescribing errors resulting in ADRs, particularly those due to drug allergies, often result from poor medical record documentation. These factors are examined in the following section.
Health information documentation and prescribing issues
An Australian hospital accreditation standard mandates documentation of any allergies in the medical record (ACHS 2010). The location of allergy information within medical records varies between organisations, common sites being the Medication and Anaesthetic forms 4 , and/or a form specifically designed for allergy recording; an allergy alert is also recorded on the front cover of the paper medical record. For consistency in practice, hospitals need to have clear, current, easily accessible policies and procedures on documentation requirements.
A major initiative of the Australian Commission on Safety and Quality in Health Care (ACSQHC) is to increase the safe use of medicines through standardisation of hospitals' medication ordering processes (ACSQHC 2010a). Recently released national standards address this issue, including, for example, the requirement that 'Known medication allergies and adverse drug reactions are documented in the patient clinical record' (ACSQHC 2011: 37) .
In 2006-2007 a standard National Inpatient Medication Chart (NIMC) 5 , mandated by Australia's Health Ministers, was introduced (Coombes et al. 2009; ACSQHC 2010b) . The ACSQHC reported a subsequent reduction in ADRs (Roughead & Bedford 2010; ACSQHC 2010a) . Conversely, a study in a large teaching hospital by Millar et al. (2008) suggested that these proclaimed benefits had not eventuated, and the NIMC may in fact contribute to an increase in medication errors. They concluded: 'The NIMC contains adverse design features and is inferior to the medication chart previously in use […and…] the purported advantages of introducing a national standard chart were not experienced' (p. 95). The ACSQHC later reported that while its 2010 NIMC audit revealed improvements, some areas experienced little change or a decline in prescribing safety; for example, the 77.3% documentation of a previous ADR reflected improvement, but there was only 45% compliance with ADR alert stickers (ACSQHC 2012).
Flaws in the system
In an exhaustive review of studies on the reporting of ADRs in the international literature, Lopez-Gonzalez, Herdeiro and Figueiras (2009) came to this alarming conclusion:
Factors associated with under-reporting were ignorance (only severe ADRs need to be reported) in 95%; diffidence (fear of appearing ridiculous for reporting merely suspected ADRs) in 72%; lethargy (an amalgam of procrastination, lack of interest or time to find a report card, and other excuses) in 77%; indifference (the one case that an individual doctor might see could not contribute to medical knowledge) and insecurity (it is nearly impossible to determine whether or not a drug is responsible for a particular adverse reaction) in 67%;
and complacency (only safe drugs are allowed on the market) in 47% of studies (Lopez-Gonzalez, Herdeiro & Figueiras 2009: 19) .
To some extent, this explains why allergy information in medical records is often inadequate. Other studies illustrate the shortcomings in recording practice; for example a study of prescriptions in a Scottish hospital revealed the omission of allergy information on 36% of medication forms (Alyamani, Hopf & Williams 2009) . In an English renal dialysis unit, whose patients were wellknown to staff, 36% of the medical records did not have all drug allergies documented (81% being drug-related) (Bhandari et al. 2008) , an audit in a South African hospital revealed that allergies were absent in 59% of medical records (Chamisa & Zulu 2007) , while in an Irish study, allergy documentation was omitted on 30% of preoperative forms (Farooq, Kirke & Foley 2008) . A medical record audit in a UK District General Hospital found inadequate allergy documentation, mainly attributed to poor form design making it difficult for doctors to enter allergy information (Gay, Hill & Bell 2009 ; see also Smith, Dang & Lee 2009 ). After studying how recorded antibiotic allergies affect a doctor's drug selection, Lutomski et al. (2008) reported that 'Discrepancies between the medical record and in-depth allergy histories are common, and the validity of reported allergic reactions is frequently questionable' (p. 1348). Another factor is that sensitivity Forum to herbal and alternative medicines which could have malign effects is not always recorded (Fitzgerald 2009 ).
Poor documentation is not necessarily a result only of inattention to detail; clear definitions are crucial in avoiding false identification of allergies (Capel et al. 2009; Gay, Hill & Bell 2009 ). Capel et al. (2009) also found in their study of the accuracy of an antibiotic questionnaire in hospital medical records that whereas allergies were suspected in 12% of patients, only 5% fulfilled the allergy criteria. The authors recommended 'periodical training about antibiotic allergy definition' (p.210) to avoid false alerts.
The hierarchical nature of hospital culture together with stressful working conditions contribute to prescribing errors, including those leading to allergic reactions. Nichols et al. (2008) , for example, examined the context of medication errors in a WA hospital, and found they can be due to 'slips in attention that occurred during routine prescribing, dispensing or drug administration' (p. 276), or knowledge-based. Significantly, the authors found that errors were more likely to occur during the busiest times, with unfamiliar or older patients, or when prescribing psychotropic and unfamiliar drugs. Pharmaceutical knowledge alone would not therefore protect against prescribing errors.
Also in Australia, a qualitative study of interns' prescribing errors in a large teaching hospital demonstrated a range of causative factors, including inexperience and poor knowledge of drugs. A failure of communication due to heavy workloads leading to fatigue, unquestioning reliance on senior doctors' prescribing, carelessness and lack of experience, team (hierarchical) issues, and patient factors (difficulty of communicating with patients about allergies etc.) are characteristic problems in this setting (Coombes et al. 2008) . Another Australian study, of referral letters for hospital oral and maxillofacial treatment, revealed that referring dentists were more likely to advise of ADRs (85%) than were referring doctors (50%) (DeAngelis, Chambers & Hall 2010) .
Patient input to allergy information
A review conducted by van Grootheest and van den Berg (2004) , found few reports had been published on the topic of patient input to allergy information. Later studies have shown that because patient-doctor communication can be inadequate (Sohel, Clark & Paton 2009; Lutomski et al. 2008) , the difference between a patient's and doctor's perception of an allergy can result in inaccurate documentation and subsequent prescribing errors. In addition, Dormann et al. (2003) found that allergies acquired outside the healthcare setting are sometimes not recognised upon hospital admission.
Access to drug allergy information by other health professionals
Dentists, podiatrists, nurse practitioners and other health professionals who are authorised to prescribe and use drugs in their practices also need access to information about their patients' negative reactions to drugs, including so-called recreational drugs (Bullock 1999) . Rafiq (2007) reports that intolerance to common drugs such as aspirin, although rare, is becoming more common and records of these allergies need to be readily available to dentists. (See also DeAngelis, Chambers & Hall 2010; Sambrook et al. 2011) .
Improving the situation
Electronic records: the end of prescribing errors?
Clearly, documentation of ADRs is susceptible to errors. The advent of electronic, or e-prescribing, however, has not necessarily spelled the end of prescribing errors; deficiencies in software design together with serious flaws in drug allergy alerts and information about 'clinically relevant' drug interactions leave users of e-systems vulnerable to error (Smith, Dang & Lee 2009 ).
The transition from paper to electronic health records (EHRs), which support the capacity for e-prescribing, is being promoted in many countries, and to boost this drive it is politically necessary to demonstrate the relative efficacy of e-systems. To this end Abramson et al. (2011) undertook a comparative study of paper and e-prescribing systems in ambulatory care, where, they claim, a relatively high rate of prescribing errors occurs. They identified a significant reduction in prescribing errors by adopters of e-prescribing over the period [2005] [2006] [2007] [2008] ; in addition they noted that illegibility was (unsurprisingly) reduced to zero in the e-system. Encouragingly, Westbrook et al. (2012) found that e-prescribing systems reduced prescribing error rates and serious clinical errors in two Sydney, Australia, teaching hospitals.
The findings are not consistently positive, however; for example, a study by Driscoll, Columbia and Peterfreund (2007) of anaesthesia records revealed that despite suggestions that EHRs in this area could overcome the deficiencies inherent in handwritten documentation; the e-version was still susceptible to significant error. They concluded that: 'Dependence on free text remarks and the record keeping system's inability to automatically present entries in logical sequences consistent with workflow were associated with incomplete data entry' (p.1454). Similarly, in a recent evaluation of the prototype of an e-medication management system, Ammenwerth et al. (2012) found that although improvements were observed, the trend was not significant when compared with the existing system.
Computerised physician order entry systems (CPOES) and allergy alerts
Electronic health records and e-prescribing are obviously not infallible; nevertheless the nature of this platform enables the incorporation of mechanisms to minimise prescribing errors, particularly those associated with ADRs. Forni, Chu and Fanikos (2010) , for example, observed that IT has the potential to protect patients in intensive care settings from medication error, through CPOES and clinical decision-support systems (CDSS) which include allergy alerts (see also Abookire et al. 2000; Jani, Barber & Wong 2011). Nebeker et al. (2005) also stressed the importance of decision support (alerts); they found that implementation of CPOES alone did not result in reduction of ADEs.
In evaluating the effectiveness of a CPOES for patients aged >65 years, Mattison et al. (2010) observed an immediate reduction in the prescription of potentially inappropriate medication; whilst not tailored for the institution, the system included targeted drugs used for that patient population. A similar outcome was found by Smith et al. (2006) , who concluded that alerts embedded in outpatients' EHRs resulted in reduced prescribing of contraindicated medication for elderly patients. Interestingly, this encouraging reduction in prescribingerrors did not necessarily result in better patient outcomes (Smith et al. 2006) . in the USA argued for the suppression of 'low value' alerts to minimise 'alert fatigue' in ambulatory care. They found that only a few alerts accounted for the greatest benefits: when extrapolated, the estimated annual savings was $US6.7 million in one state alone (Massachusetts). Sandberg et al. (2008) described an alert system designed to ensure that electronic anaesthesia documentation was entered correctly. They found that before initiating the alert system, allergy comment was missing on 30% of medication forms, decreasing to 8% after its establishment.
It should be noted here that the validity of some research has been questioned. Reckman et al. (2009) conducted a review of studies of the effectiveness of CPOES in reducing prescribing errors which revealed: 'The evidence-base reporting the effectiveness of CPOES to reduce prescribing errors is not compelling ' (p. 16) . This is partly due to the fact that many studies appear to be undermined by flawed methodology, for example by limited sampling and lack of clear definition of the severity of errors.
Overriding allergy alerts
For a number of reasons, doctors frequently override drug allergy (and drug-drug interaction) alerts. For example, a review by van der Sijs et al. (2006) indicated that drug alerts were overridden in 49% to 96% of cases reviewed. The authors urged a distinction between 'appropriate' and 'useful' alerts, to overcome the problems of lack of specificity or sensitivity in alerts. They found that '[t]he alerting system may contain error-producing conditions like low specificity, low sensitivity, unclear information content, unnecessary workflow disruptions, and unsafe and inefficient handling. These may result in active failures of the physician, like ignoring alerts, misinterpretation, and incorrect handling' (p.138). Hsieh et al. (2004) concluded from a three-month observation in a large academic hospital that overrides were common and, in many cases, justified (resulting in few ADEs). Undue sensitivity and lack of currency of alerts are major causal factors. In studying primary care practices, for example, Weingart et al. (2003) found that doctors overrode 91.2% of drug allergy and 89.4% of 'high-severity drug interaction' alerts, 35% of these alerts being judged as 'inappropriate' by reviewers. Weingart, Simchowitz, Shiman et al. (2009) , in a later study of ambulatory care facilities, found that despite acknowledging improvement in patient safety by avoidance of prescribing errors, 47% of correspondents expressed dissatisfaction with the allergy and drug interaction alerts. Weingart, Simchowitz, Podolsky et al. (2009) recommend mitigation against 'alert fatigue', noting that ADE avoidance in the ambulatory care setting under study could be attributed to the few alerts that had been observed (Weingart, Simchowitz, Podolsky et al. 2009 ; see also Shah et al. 2006) . The non-contextual nature of CDSS alerts is another reason for doctors' decisions to override them (Taylor & Tamblyn 2004) .
In a recent study in a UK tertiary paediatric hospital, Jani, Barber and Wong (2011) found that 89% of all CDSS alerts were overridden at the point of prescribing, but of these, drug allergy alerts were the most readily accepted by doctors. A similar respect for allergy alerts was identified by Isaac et al. (2009) , who analysed 233,537 medication safety alerts in ambulatory care settings. Whilst most medication alerts were overridden, 23% of allergy alerts and only 9.2% of drug interaction alerts were accepted. The authors concluded that 'medication alerts may be inadequate to protect patient safety ' (p. 305) .
It would appear that despite the promise of allergy alerts in CPOES as a means of reducing, if not entirely avoiding, medication errors, to be effective the system requires constant vigilance (Abookire et al. 2000) . In a study by Strom et al. (2010) , for example, CPOE was found to be very effective in reducing prescribing error in a particular case, namely, the simultaneous ordering of warfarin (an anticoagulant) and trimethoprim-sulfamethoxazole (an antibiotic that enhances the effect of warfarin and can induce adverse bleeding). However, in some cases, due to observation of the alert, the antibiotic was not prescribed to critically ill patients. This underlines the importance of ongoing, system evaluation and monitoring (Strom et al. 2010 ).
The role of non-medical staff in allergy documentation
The role of non-medical staff in the input of allergy information to medical records is important, and in some cases demonstrably effective in increasing patient safety by identifying potential sources of prescribing error. Anoz-Jimenez et al. (2011) , for example, made an intensive study of nurses' interventions in a hospital Pharmaceutical Care Unit involving 1,360 patients with a total of 1709 interventions, 111 of which were designed to identify discrepancies in the records regarding drug Forum allergies or intolerances. They found that the nurses' interventions did indeed enhance the 'effectiveness, safety and efficiency' of pharmacotherapy. A similar finding was found by Ortega et al. (2008) who were interested in ADR reporting in post-marketing drug surveillance databases. They concluded that nurses had a valuable role: ' Allowing nurses to report ADRs in a manner similar to that of physicians and pharmacists, as well as automatic entry of certain data into the form, contributes to the improvement of the system' (p. 1491).
There is always the possibility of 'demarcation disputes' when doctors perceive the exclusivity of their roles to be under threat, but a study by Ekman and Backstrom (2009) on doctors' attitudes to nurses' input to ADR reporting showed that the former were generally positive or neutral to this role. Encouragingly, 'only 6% stated that their willingness to report ADRs would be affected in a negative way if nurses were involved in the program for reporting' (p. 43).
As expected, hospital pharmacists have a significant role in reporting and recording of allergic and other drug reactions. Significantly, an analysis showed a marked reduction ADRs in 584 USA hospitals that offered 'pharmacist-provided admission drug histories' (Bond & Raehl 2006) . Furthermore, while evaluating the effectiveness of a CPOES in reducing prescribing errors in a USA community hospital Jayawardena et al. (2007) concluded that: 'Involvement of the pharmacist in reviewing the prescription and alerting the physician has minimized prescription errors to a great degree in our hospital setting' (p. 336). Finally, pharmacists' expertise was used by Jabbour et al. (2002) to evaluate the accuracy of allergy documentation for patients prescribed vancomycin. The conclusion was that the 'pharmacist's assessment and clarification of allergy information was a crucial element in safeguarding the patient from potential harm' (p.21).
Medication reconciliation
These and other studies (e.g. Kuo et al. 2008; Sullivan & Spooner 2008) substantiate the important role of other health professions in reducing ADRs due to prescribing errors. Their participation, particularly of pharmacists, is crucial in the medication reconciliation process (Burridge 2007), which is defined by Queensland Health as follows: Medication reconciliation is an important 'practice tool' for reducing medication errors in intensive care units (Pronovost et al. 2003) , tertiary settings (Kramer et al. 2007; Murphy et al. 2009 ), emergency departments (Hayes et al. 2007) , and pre-operative clinics (van den Berg et al. 2009 ). There is potential for medication errors to occur at admission and discharge of patients in acute care environments, allergic reactions to drugs being of primary concern. In a program to improve patient safety in these settings, Bayley et al. (2007) found that identification of allergies by transitional care pharmacists at admission, together with a detailed follow-up program, were 'key contributions' to reducing morbidity. The efficiency and superior accuracy of pharmacists in taking medication histories were also demonstrated by Hayes et al. (2007) .
A comparative study by Kramer et al. (2007) revealed that implementation of electronic reconciliation is more efficient and more easily understood by patients than conventional methods of reconciliation. However, reliance solely upon the EHR has its pitfalls: Moore et al. (2011) found in their study of an English hospital that although it can reduce medication errors, it is not necessarily more reliable than conventional records for reconciliation. They recommended that 'both primary care and hospital clinicians should have read-and-write access to the EHR to reduce errors at care transitions' (p. 148).
ICD coding of ADRs
Diagnostic coding might be expected to play a critical role in providing reliable evidence of ADR incidence and cost to the healthcare system, and in safeguarding patients from potentially injurious or fatal prescribing errors. However, it has been found in several countries that ICD coding of ADRs is not always accurate or complete, generally attributable to the classification (coding system), under-coding, or poor coding (possibly due to coders' lack of clinical knowledge, or classificatory incompetence).
In England, Cox et al. (2001) found that the ICD-10 coding in a large teaching hospital identified important ADRs that doctors 'would not report spontaneously' (p. 339). In contrast, Waller et al. (2005) reported a stable number of patients with 'drug-induced' codes throughout their five-year (1995-2000) study of the English national coded (ICD-10) dataset, but a low concordance with External Cause codes which, overall, had increased by 40%. They concluded that ADRs/drug-induced disorders were under-reported, under-recorded and affected by coding system limitations (Waller et al. 2005) . Patel et al. (2007) later found that although ADRs had increased as a percentage of all English hospital admissions from 1998-2005; there was ongoing under-recording (and, therefore, under-coding) .
In the USA, Chyka (2000) identified hugely discrepant ADR mortality data in key sources, namely underreporting via ICD-9 coded death certificates, compared with post-marketing surveillance data. He recommended Forum more comprehensive data to underpin drug safety policies. In Australia, research by Runciman et al. (2003) using ICD-10-AM coded data from the national dataset and the state of South Australia showed that: 'Routine death certificate and hospital discharge data coded using the International Classification of Diseases capture less than half as many ADEs as medical record reviews' (p.149). Mittmann and Knowles (2004) in Canada observed extensive under-reporting in ICD-9-CM of toxic epidermal necrolysis, a potentially life-threatening ADR. Similarly, Backstrom, Mjorndal & Dahlqvist (2004) in Sweden found 82% under-reporting, in ICD-10, of all ADRs during their 1996-2000 study.
In reviewing the 1999-2002, ICD-10 coded data in Brazil's national hospital database, Rozenfeld (2007) identified an ADE ratio (the majority being ADRs) of 1.8 cases: 1,000 hospitalisations, and an associated, significantly longer ALOS (26.5 versus 5.0 days). In Saudi Arabia, an examination of the 1982-2005, ICD-9 coded ADR data reflected under-reporting, and possible coding system limitations (Al-Malaq, Al-Aqeel & Al-Sultan 2008) . Similarly, in their Slovenian medical record review, Brvar et al. (2009) found that ADRs comprised 5.8% of admissions and, although documented satisfactorily in the medical record, were massively under-coded by 96.7%, attributed partly to the treating doctors' responsibility for ICD-10 coding. The authors recommended employment of expert coders, and the specialist (pharmacovigilance) Medical Dictionary for Regulatory Activities.
Following their 10-year (above-mentioned), UK study using ICD-10 coded data, Wu et al. (2010) ascribed the massive increase in annual ADR reporting, including in-hospital mortality, to improved ICD-10 diagnostic coding; they cautioned of the need to reduce ADRs and to improve their recording. Carrasco-Garrido et al. (2010) (afore-mentioned) used Spain's national ICD-9 data to identify the 2001-2006 ADR-related hospital admissions.
In France, an increase in ADR-related admissions in 1989-2010 in a paediatric teaching hospital was attributed to the implementation of ICD coding and, mainly, to more complete coding by medical archivists (similar to Health Information Managers) following the hospital management's prioritisation of the coding function (Huet et al. 2011) .
State or national ICD-coded datasets can provide a baseline to identify ADR-related diagnoses for comparison with diagnostic test results. In the Netherlands, van den Berg et al. (2009) , for instance, scrutinised the Utrecht Patient Oriented Database's ICD-9-CM data, and demonstrated that clinical laboratory data are more sensitive in identifying patients with potential drug-induced thrombocytopenia.
The sensitivity of ICD-10 coding was found to be questionable in a study of Finnish hospital admissions conducted by Juntti-Patinen et al. (2006) . Similarly, Benkhaial et al. (2009) found in Germany that several ICD-10 codes for drug allergies were 'often ambiguous, infrequently used, and therefore of limited value' (p. 464). They surmised that other factors leading to intercountry variability were likely to relate to differences in coding policies, availability of confirmatory clinical evidence, relevance to reimbursement, and non-clinical coders' skills which may produce inaccurate coding.
It would seem, then, that there are several vital factors: doctors' diagnostic and pharmaceutical knowledge and ADR reporting practice; documentation of alerts and ADRs in the medical record; a robust classification; and competent, expert coders. It remains to be seen whether the specificity and sensitivity of the modified versions of the ICD in various countries will ultimately provide more accurate and comprehensive evidence of ADRs.
7
Conclusion
Adverse Drug Reactions constitute a largely preventable problem that imposes substantial morbidity, mortality and financial costs on individuals, hospitals and the community. This patient safety issue spans admitted and community-based healthcare environments. It is imbued with multi-factorial clinical, pharmacological, human, technological system, and health information management complexities, surrounding: clinical practice; drug-drug interactions and patient sensitivities; alert and prescribing systems, including CPOES; paper and e-forms, EHRs, and medical record systems; medical reconciliation and involvement of non-doctor health professionals; reporting and documentation; the ICD classification; and expert clinical coding. (Another major component, pharmacovigilance, was not addressed.)
The availability and reliability of ADR statistics can be compromised by irregularities in data collection and patient-related documentation, and prescribing errors resulting in ADRs, especially drug allergy-related, often results from poor medical record documentation. The weight of international evidence is ambivalent, thus far, on two key aspects. First, the efficacy of local electronic systems for the identification and prevention of ADRs remains below par. Second, there is extensive under-documenting and, therefore, under-reporting and under-coding of ADRs.
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